nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A4—Temozolomide—malignant glioma	0.122	1	CbGbCtD
Oxybutynin—Tongue discolouration—Temozolomide—malignant glioma	0.0148	0.0279	CcSEcCtD
Oxybutynin—Paranoia—Carmustine—malignant glioma	0.0108	0.0204	CcSEcCtD
Oxybutynin—Lung disorder—Temozolomide—malignant glioma	0.0101	0.019	CcSEcCtD
Oxybutynin—Memory impairment—Temozolomide—malignant glioma	0.0091	0.0172	CcSEcCtD
Oxybutynin—Accidental injury—Carmustine—malignant glioma	0.00835	0.0157	CcSEcCtD
Oxybutynin—Thinking abnormal—Carmustine—malignant glioma	0.00807	0.0152	CcSEcCtD
Oxybutynin—Dry eye—Temozolomide—malignant glioma	0.00659	0.0124	CcSEcCtD
Oxybutynin—Abnormal vision—Carmustine—malignant glioma	0.00644	0.0122	CcSEcCtD
Oxybutynin—Mental disability—Carmustine—malignant glioma	0.00641	0.0121	CcSEcCtD
Oxybutynin—Abnormal vision—Temozolomide—malignant glioma	0.00623	0.0117	CcSEcCtD
Oxybutynin—Mental disability—Temozolomide—malignant glioma	0.00619	0.0117	CcSEcCtD
Oxybutynin—Eye pain—Carmustine—malignant glioma	0.00594	0.0112	CcSEcCtD
Oxybutynin—Injury—Carmustine—malignant glioma	0.00583	0.011	CcSEcCtD
Oxybutynin—Eye pain—Temozolomide—malignant glioma	0.00574	0.0108	CcSEcCtD
Oxybutynin—Amnesia—Carmustine—malignant glioma	0.00571	0.0108	CcSEcCtD
Oxybutynin—Nasal congestion—Temozolomide—malignant glioma	0.00569	0.0107	CcSEcCtD
Oxybutynin—Hot flush—Temozolomide—malignant glioma	0.00554	0.0104	CcSEcCtD
Oxybutynin—Amnesia—Temozolomide—malignant glioma	0.00552	0.0104	CcSEcCtD
Oxybutynin—Menopausal symptoms—Temozolomide—malignant glioma	0.00549	0.0104	CcSEcCtD
Oxybutynin—Thirst—Temozolomide—malignant glioma	0.00544	0.0103	CcSEcCtD
Oxybutynin—Face oedema—Carmustine—malignant glioma	0.00518	0.00976	CcSEcCtD
Oxybutynin—Affect lability—Temozolomide—malignant glioma	0.0051	0.00962	CcSEcCtD
Oxybutynin—Face oedema—Temozolomide—malignant glioma	0.005	0.00944	CcSEcCtD
Oxybutynin—Liver function test abnormal—Carmustine—malignant glioma	0.00495	0.00934	CcSEcCtD
Oxybutynin—Mood swings—Temozolomide—malignant glioma	0.00491	0.00926	CcSEcCtD
Oxybutynin—Dry skin—Temozolomide—malignant glioma	0.00475	0.00896	CcSEcCtD
Oxybutynin—Breast disorder—Temozolomide—malignant glioma	0.00468	0.00883	CcSEcCtD
Oxybutynin—Dysphagia—Carmustine—malignant glioma	0.00463	0.00874	CcSEcCtD
Oxybutynin—Abdominal distension—Temozolomide—malignant glioma	0.00451	0.0085	CcSEcCtD
Oxybutynin—Dysphagia—Temozolomide—malignant glioma	0.00448	0.00845	CcSEcCtD
Oxybutynin—Bronchitis—Temozolomide—malignant glioma	0.00431	0.00812	CcSEcCtD
Oxybutynin—Dysuria—Temozolomide—malignant glioma	0.00419	0.0079	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00416	0.00785	CcSEcCtD
Oxybutynin—Pollakiuria—Temozolomide—malignant glioma	0.00414	0.0078	CcSEcCtD
Oxybutynin—Erectile dysfunction—Temozolomide—malignant glioma	0.00412	0.00778	CcSEcCtD
Oxybutynin—Depression—Carmustine—malignant glioma	0.00412	0.00777	CcSEcCtD
Oxybutynin—Stomatitis—Carmustine—malignant glioma	0.00403	0.0076	CcSEcCtD
Oxybutynin—Urinary tract infection—Carmustine—malignant glioma	0.00402	0.00758	CcSEcCtD
Oxybutynin—Infestation NOS—Temozolomide—malignant glioma	0.00399	0.00753	CcSEcCtD
Oxybutynin—Infestation—Temozolomide—malignant glioma	0.00399	0.00753	CcSEcCtD
Oxybutynin—Depression—Temozolomide—malignant glioma	0.00398	0.00751	CcSEcCtD
Oxybutynin—Stomatitis—Temozolomide—malignant glioma	0.00389	0.00734	CcSEcCtD
Oxybutynin—Urinary tract infection—Temozolomide—malignant glioma	0.00388	0.00732	CcSEcCtD
Oxybutynin—Sinusitis—Temozolomide—malignant glioma	0.00375	0.00707	CcSEcCtD
Oxybutynin—Hypoaesthesia—Carmustine—malignant glioma	0.00369	0.00696	CcSEcCtD
Oxybutynin—Hallucination—Carmustine—malignant glioma	0.00369	0.00696	CcSEcCtD
Oxybutynin—Oedema peripheral—Carmustine—malignant glioma	0.00365	0.00689	CcSEcCtD
Oxybutynin—Connective tissue disorder—Carmustine—malignant glioma	0.00365	0.00688	CcSEcCtD
Oxybutynin—Visual impairment—Carmustine—malignant glioma	0.00357	0.00674	CcSEcCtD
Oxybutynin—Hallucination—Temozolomide—malignant glioma	0.00357	0.00673	CcSEcCtD
Oxybutynin—Hypoaesthesia—Temozolomide—malignant glioma	0.00357	0.00673	CcSEcCtD
Oxybutynin—Pharyngitis—Temozolomide—malignant glioma	0.00356	0.00671	CcSEcCtD
Oxybutynin—Urinary tract disorder—Temozolomide—malignant glioma	0.00354	0.00668	CcSEcCtD
Oxybutynin—Oedema peripheral—Temozolomide—malignant glioma	0.00353	0.00666	CcSEcCtD
Oxybutynin—Connective tissue disorder—Temozolomide—malignant glioma	0.00352	0.00664	CcSEcCtD
Oxybutynin—Urethral disorder—Temozolomide—malignant glioma	0.00351	0.00663	CcSEcCtD
Oxybutynin—Eye disorder—Carmustine—malignant glioma	0.00347	0.00654	CcSEcCtD
Oxybutynin—Visual impairment—Temozolomide—malignant glioma	0.00345	0.00652	CcSEcCtD
Oxybutynin—Flushing—Carmustine—malignant glioma	0.00344	0.00649	CcSEcCtD
Oxybutynin—Eye disorder—Temozolomide—malignant glioma	0.00335	0.00632	CcSEcCtD
Oxybutynin—Tinnitus—Temozolomide—malignant glioma	0.00334	0.0063	CcSEcCtD
Oxybutynin—Flushing—Temozolomide—malignant glioma	0.00333	0.00627	CcSEcCtD
Oxybutynin—Cardiac disorder—Temozolomide—malignant glioma	0.00333	0.00627	CcSEcCtD
Oxybutynin—Arrhythmia—Carmustine—malignant glioma	0.00331	0.00625	CcSEcCtD
Oxybutynin—Angiopathy—Temozolomide—malignant glioma	0.00325	0.00613	CcSEcCtD
Oxybutynin—Mental disorder—Carmustine—malignant glioma	0.00325	0.00613	CcSEcCtD
Oxybutynin—Mediastinal disorder—Temozolomide—malignant glioma	0.00323	0.00609	CcSEcCtD
Oxybutynin—Erythema—Carmustine—malignant glioma	0.00323	0.00609	CcSEcCtD
Oxybutynin—Malnutrition—Carmustine—malignant glioma	0.00323	0.00609	CcSEcCtD
Oxybutynin—Mental disorder—Temozolomide—malignant glioma	0.00314	0.00592	CcSEcCtD
Oxybutynin—Back pain—Carmustine—malignant glioma	0.00312	0.00589	CcSEcCtD
Oxybutynin—Erythema—Temozolomide—malignant glioma	0.00312	0.00589	CcSEcCtD
Oxybutynin—Malnutrition—Temozolomide—malignant glioma	0.00312	0.00589	CcSEcCtD
Oxybutynin—Dysgeusia—Temozolomide—malignant glioma	0.00306	0.00576	CcSEcCtD
Oxybutynin—Vision blurred—Carmustine—malignant glioma	0.00304	0.00574	CcSEcCtD
Oxybutynin—Back pain—Temozolomide—malignant glioma	0.00302	0.00569	CcSEcCtD
Oxybutynin—Agitation—Carmustine—malignant glioma	0.00297	0.0056	CcSEcCtD
Oxybutynin—Vision blurred—Temozolomide—malignant glioma	0.00294	0.00555	CcSEcCtD
Oxybutynin—Ill-defined disorder—Temozolomide—malignant glioma	0.0029	0.00546	CcSEcCtD
Oxybutynin—Agitation—Temozolomide—malignant glioma	0.00287	0.00541	CcSEcCtD
Oxybutynin—Angioedema—Temozolomide—malignant glioma	0.00285	0.00538	CcSEcCtD
Oxybutynin—Malaise—Temozolomide—malignant glioma	0.00281	0.00531	CcSEcCtD
Oxybutynin—Convulsion—Carmustine—malignant glioma	0.0028	0.00528	CcSEcCtD
Oxybutynin—Hypertension—Carmustine—malignant glioma	0.00279	0.00526	CcSEcCtD
Oxybutynin—Palpitations—Temozolomide—malignant glioma	0.00276	0.0052	CcSEcCtD
Oxybutynin—Chest pain—Carmustine—malignant glioma	0.00275	0.00519	CcSEcCtD
Oxybutynin—Anxiety—Carmustine—malignant glioma	0.00274	0.00517	CcSEcCtD
Oxybutynin—Cough—Temozolomide—malignant glioma	0.00272	0.00514	CcSEcCtD
Oxybutynin—Convulsion—Temozolomide—malignant glioma	0.0027	0.0051	CcSEcCtD
Oxybutynin—Hypertension—Temozolomide—malignant glioma	0.00269	0.00508	CcSEcCtD
Oxybutynin—Confusional state—Carmustine—malignant glioma	0.00266	0.00501	CcSEcCtD
Oxybutynin—Arthralgia—Temozolomide—malignant glioma	0.00266	0.00501	CcSEcCtD
Oxybutynin—Anxiety—Temozolomide—malignant glioma	0.00265	0.00499	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00264	0.00498	CcSEcCtD
Oxybutynin—Oedema—Carmustine—malignant glioma	0.00264	0.00497	CcSEcCtD
Oxybutynin—Discomfort—Temozolomide—malignant glioma	0.00262	0.00495	CcSEcCtD
Oxybutynin—Infection—Carmustine—malignant glioma	0.00262	0.00494	CcSEcCtD
Oxybutynin—Dry mouth—Temozolomide—malignant glioma	0.0026	0.0049	CcSEcCtD
Oxybutynin—Tachycardia—Carmustine—malignant glioma	0.00257	0.00485	CcSEcCtD
Oxybutynin—Confusional state—Temozolomide—malignant glioma	0.00257	0.00484	CcSEcCtD
Oxybutynin—Anaphylactic shock—Temozolomide—malignant glioma	0.00255	0.0048	CcSEcCtD
Oxybutynin—Oedema—Temozolomide—malignant glioma	0.00255	0.0048	CcSEcCtD
Oxybutynin—Infection—Temozolomide—malignant glioma	0.00253	0.00477	CcSEcCtD
Oxybutynin—Anorexia—Carmustine—malignant glioma	0.00251	0.00474	CcSEcCtD
Oxybutynin—Nervous system disorder—Temozolomide—malignant glioma	0.0025	0.00471	CcSEcCtD
Oxybutynin—Skin disorder—Temozolomide—malignant glioma	0.00247	0.00467	CcSEcCtD
Oxybutynin—Hypotension—Carmustine—malignant glioma	0.00246	0.00464	CcSEcCtD
Oxybutynin—Anorexia—Temozolomide—malignant glioma	0.00243	0.00458	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.0024	0.00453	CcSEcCtD
Oxybutynin—Insomnia—Carmustine—malignant glioma	0.00238	0.0045	CcSEcCtD
Oxybutynin—Paraesthesia—Carmustine—malignant glioma	0.00237	0.00446	CcSEcCtD
Oxybutynin—Somnolence—Carmustine—malignant glioma	0.00234	0.00442	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00232	0.00438	CcSEcCtD
Oxybutynin—Insomnia—Temozolomide—malignant glioma	0.0023	0.00434	CcSEcCtD
Oxybutynin—Decreased appetite—Carmustine—malignant glioma	0.00229	0.00432	CcSEcCtD
Oxybutynin—Paraesthesia—Temozolomide—malignant glioma	0.00229	0.00431	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00228	0.00429	CcSEcCtD
Oxybutynin—Somnolence—Temozolomide—malignant glioma	0.00226	0.00427	CcSEcCtD
Oxybutynin—Constipation—Carmustine—malignant glioma	0.00225	0.00425	CcSEcCtD
Oxybutynin—Pain—Carmustine—malignant glioma	0.00225	0.00425	CcSEcCtD
Oxybutynin—Dyspepsia—Temozolomide—malignant glioma	0.00224	0.00423	CcSEcCtD
Oxybutynin—Decreased appetite—Temozolomide—malignant glioma	0.00221	0.00418	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.0022	0.00415	CcSEcCtD
Oxybutynin—Fatigue—Temozolomide—malignant glioma	0.0022	0.00414	CcSEcCtD
Oxybutynin—Pain—Temozolomide—malignant glioma	0.00218	0.00411	CcSEcCtD
Oxybutynin—Constipation—Temozolomide—malignant glioma	0.00218	0.00411	CcSEcCtD
Oxybutynin—Feeling abnormal—Carmustine—malignant glioma	0.00217	0.0041	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Carmustine—malignant glioma	0.00216	0.00406	CcSEcCtD
Oxybutynin—Feeling abnormal—Temozolomide—malignant glioma	0.0021	0.00396	CcSEcCtD
Oxybutynin—Abdominal pain—Carmustine—malignant glioma	0.00208	0.00393	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00208	0.00393	CcSEcCtD
Oxybutynin—Urticaria—Temozolomide—malignant glioma	0.00202	0.00382	CcSEcCtD
Oxybutynin—Abdominal pain—Temozolomide—malignant glioma	0.00201	0.0038	CcSEcCtD
Oxybutynin—Hypersensitivity—Carmustine—malignant glioma	0.00194	0.00366	CcSEcCtD
Oxybutynin—Asthenia—Carmustine—malignant glioma	0.00189	0.00357	CcSEcCtD
Oxybutynin—Hypersensitivity—Temozolomide—malignant glioma	0.00188	0.00354	CcSEcCtD
Oxybutynin—Asthenia—Temozolomide—malignant glioma	0.00183	0.00345	CcSEcCtD
Oxybutynin—Diarrhoea—Carmustine—malignant glioma	0.0018	0.0034	CcSEcCtD
Oxybutynin—Pruritus—Temozolomide—malignant glioma	0.0018	0.0034	CcSEcCtD
Oxybutynin—Dizziness—Carmustine—malignant glioma	0.00174	0.00329	CcSEcCtD
Oxybutynin—Diarrhoea—Temozolomide—malignant glioma	0.00174	0.00329	CcSEcCtD
Oxybutynin—Dizziness—Temozolomide—malignant glioma	0.00168	0.00318	CcSEcCtD
Oxybutynin—Vomiting—Carmustine—malignant glioma	0.00168	0.00316	CcSEcCtD
Oxybutynin—Rash—Carmustine—malignant glioma	0.00166	0.00313	CcSEcCtD
Oxybutynin—Dermatitis—Carmustine—malignant glioma	0.00166	0.00313	CcSEcCtD
Oxybutynin—Headache—Carmustine—malignant glioma	0.00165	0.00311	CcSEcCtD
Oxybutynin—Vomiting—Temozolomide—malignant glioma	0.00162	0.00305	CcSEcCtD
Oxybutynin—Rash—Temozolomide—malignant glioma	0.00161	0.00303	CcSEcCtD
Oxybutynin—Dermatitis—Temozolomide—malignant glioma	0.0016	0.00303	CcSEcCtD
Oxybutynin—Headache—Temozolomide—malignant glioma	0.0016	0.00301	CcSEcCtD
Oxybutynin—Nausea—Carmustine—malignant glioma	0.00157	0.00295	CcSEcCtD
Oxybutynin—Nausea—Temozolomide—malignant glioma	0.00151	0.00285	CcSEcCtD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCL8—malignant glioma	6.97e-05	0.0002	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCL8—malignant glioma	6.95e-05	0.0002	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTK2—malignant glioma	6.91e-05	0.000198	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCL8—malignant glioma	6.88e-05	0.000198	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HES1—malignant glioma	6.88e-05	0.000198	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HES1—malignant glioma	6.86e-05	0.000197	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NCOR1—malignant glioma	6.85e-05	0.000197	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NCOR1—malignant glioma	6.84e-05	0.000196	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NCOR1—malignant glioma	6.82e-05	0.000196	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HES1—malignant glioma	6.79e-05	0.000195	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—BRAF—malignant glioma	6.78e-05	0.000195	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NCOR1—malignant glioma	6.75e-05	0.000194	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RAF1—malignant glioma	6.75e-05	0.000194	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RAF1—malignant glioma	6.72e-05	0.000193	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—BCHE—malignant glioma	6.67e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—IL2—malignant glioma	6.66e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RAF1—malignant glioma	6.66e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CAV1—malignant glioma	6.65e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—IL2—malignant glioma	6.64e-05	0.000191	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT2—malignant glioma	6.6e-05	0.00019	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CB—malignant glioma	6.59e-05	0.000189	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SLC5A5—malignant glioma	6.58e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—IL2—malignant glioma	6.57e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—malignant glioma	6.57e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CB—malignant glioma	6.57e-05	0.000189	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	6.55e-05	0.000188	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PDGFRA—malignant glioma	6.55e-05	0.000188	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PDGFRA—malignant glioma	6.53e-05	0.000187	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—IDH1—malignant glioma	6.53e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CB—malignant glioma	6.5e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PDGFRA—malignant glioma	6.46e-05	0.000186	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTP1—malignant glioma	6.46e-05	0.000186	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SPP1—malignant glioma	6.36e-05	0.000183	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CD—malignant glioma	6.34e-05	0.000182	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SPP1—malignant glioma	6.34e-05	0.000182	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCL8—malignant glioma	6.33e-05	0.000182	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SPHK1—malignant glioma	6.31e-05	0.000181	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCL8—malignant glioma	6.31e-05	0.000181	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CAT—malignant glioma	6.29e-05	0.000181	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—PIK3CA—malignant glioma	6.28e-05	0.00018	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SPP1—malignant glioma	6.28e-05	0.00018	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCL8—malignant glioma	6.25e-05	0.000179	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—KRAS—malignant glioma	6.21e-05	0.000178	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2C18—malignant glioma	6.19e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—FGF2—malignant glioma	6.07e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CG—malignant glioma	6.05e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—IL2—malignant glioma	6.05e-05	0.000174	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—IL2—malignant glioma	6.03e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TERT—malignant glioma	6.03e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TERT—malignant glioma	6.01e-05	0.000173	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—IL2—malignant glioma	5.97e-05	0.000171	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TERT—malignant glioma	5.95e-05	0.000171	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NCOR1—malignant glioma	5.94e-05	0.000171	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PDGFB—malignant glioma	5.88e-05	0.000169	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PDGFB—malignant glioma	5.86e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FGFR1—malignant glioma	5.85e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PPARG—malignant glioma	5.84e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FGFR1—malignant glioma	5.83e-05	0.000168	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PDGFB—malignant glioma	5.81e-05	0.000167	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FGFR1—malignant glioma	5.78e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIF1A—malignant glioma	5.76e-05	0.000166	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIF1A—malignant glioma	5.75e-05	0.000165	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PIK3CA—malignant glioma	5.7e-05	0.000164	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIF1A—malignant glioma	5.69e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MDM2—malignant glioma	5.68e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RAF1—malignant glioma	5.66e-05	0.000163	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ERBB2—malignant glioma	5.6e-05	0.000161	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CAV1—malignant glioma	5.59e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CAV1—malignant glioma	5.57e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CAV1—malignant glioma	5.56e-05	0.00016	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CB—malignant glioma	5.53e-05	0.000159	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—malignant glioma	5.51e-05	0.000158	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CAV1—malignant glioma	5.5e-05	0.000158	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—malignant glioma	5.49e-05	0.000158	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—malignant glioma	5.44e-05	0.000156	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CD—malignant glioma	5.32e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL8—malignant glioma	5.31e-05	0.000153	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FN1—malignant glioma	5.31e-05	0.000152	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—F2—malignant glioma	5.31e-05	0.000152	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTP1—malignant glioma	5.3e-05	0.000152	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—F2—malignant glioma	5.29e-05	0.000152	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FN1—malignant glioma	5.29e-05	0.000152	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BAD—malignant glioma	5.24e-05	0.000151	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FN1—malignant glioma	5.24e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—F2—malignant glioma	5.24e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BAD—malignant glioma	5.23e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOTCH1—malignant glioma	5.19e-05	0.000149	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOTCH1—malignant glioma	5.18e-05	0.000149	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BAD—malignant glioma	5.18e-05	0.000149	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAT—malignant glioma	5.16e-05	0.000148	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AKT1—malignant glioma	5.13e-05	0.000147	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOTCH1—malignant glioma	5.13e-05	0.000147	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CG—malignant glioma	5.09e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CD80—malignant glioma	5.09e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CASP3—malignant glioma	5.08e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CG—malignant glioma	5.08e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—APC—malignant glioma	5.08e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—IL2—malignant glioma	5.07e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CD80—malignant glioma	5.07e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—APC—malignant glioma	5.06e-05	0.000145	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CG—malignant glioma	5.06e-05	0.000145	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CD80—malignant glioma	5.02e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGF—malignant glioma	5.02e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CG—malignant glioma	5.01e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—APC—malignant glioma	5.01e-05	0.000144	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—malignant glioma	5e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGF—malignant glioma	5e-05	0.000144	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTPN11—malignant glioma	4.99e-05	0.000143	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTPN11—malignant glioma	4.97e-05	0.000143	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGF—malignant glioma	4.95e-05	0.000142	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTPN11—malignant glioma	4.92e-05	0.000141	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PPARG—malignant glioma	4.91e-05	0.000141	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NCOR1—malignant glioma	4.87e-05	0.00014	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CAV1—malignant glioma	4.84e-05	0.000139	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MMP9—malignant glioma	4.8e-05	0.000138	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PTEN—malignant glioma	4.77e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—BRAF—malignant glioma	4.77e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—BRAF—malignant glioma	4.76e-05	0.000137	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—BRAF—malignant glioma	4.71e-05	0.000135	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS1—malignant glioma	4.69e-05	0.000135	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AKT1—malignant glioma	4.66e-05	0.000134	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT2—malignant glioma	4.65e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CB—malignant glioma	4.64e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT2—malignant glioma	4.63e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—malignant glioma	4.63e-05	0.000133	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	4.62e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—malignant glioma	4.61e-05	0.000132	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—malignant glioma	4.6e-05	0.000132	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT2—malignant glioma	4.59e-05	0.000132	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—malignant glioma	4.57e-05	0.000131	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CD—malignant glioma	4.47e-05	0.000129	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CD—malignant glioma	4.46e-05	0.000128	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CD—malignant glioma	4.45e-05	0.000128	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—malignant glioma	4.42e-05	0.000127	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CG—malignant glioma	4.41e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—malignant glioma	4.41e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CD—malignant glioma	4.41e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—KRAS—malignant glioma	4.37e-05	0.000126	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—malignant glioma	4.36e-05	0.000125	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—BCHE—malignant glioma	4.36e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—KRAS—malignant glioma	4.36e-05	0.000125	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—KRAS—malignant glioma	4.31e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—VEGFA—malignant glioma	4.31e-05	0.000124	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC5A5—malignant glioma	4.31e-05	0.000124	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FGF2—malignant glioma	4.27e-05	0.000123	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—STAT3—malignant glioma	4.27e-05	0.000123	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FGF2—malignant glioma	4.26e-05	0.000122	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PPARG—malignant glioma	4.25e-05	0.000122	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FGF2—malignant glioma	4.22e-05	0.000121	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—malignant glioma	4.01e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTEN—malignant glioma	4.01e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—malignant glioma	4e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MDM2—malignant glioma	4e-05	0.000115	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MDM2—malignant glioma	3.99e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAF1—malignant glioma	3.98e-05	0.000114	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CAV1—malignant glioma	3.97e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAF1—malignant glioma	3.97e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—malignant glioma	3.97e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—malignant glioma	3.96e-05	0.000114	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MDM2—malignant glioma	3.95e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—malignant glioma	3.94e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAF1—malignant glioma	3.93e-05	0.000113	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—malignant glioma	3.93e-05	0.000113	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CB—malignant glioma	3.9e-05	0.000112	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—malignant glioma	3.89e-05	0.000112	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CB—malignant glioma	3.89e-05	0.000112	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—malignant glioma	3.88e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CB—malignant glioma	3.88e-05	0.000111	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CD—malignant glioma	3.88e-05	0.000111	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—malignant glioma	3.86e-05	0.000111	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CB—malignant glioma	3.84e-05	0.00011	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL8—malignant glioma	3.74e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL8—malignant glioma	3.73e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL8—malignant glioma	3.69e-05	0.000106	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KRAS—malignant glioma	3.67e-05	0.000105	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CG—malignant glioma	3.62e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AKT1—malignant glioma	3.61e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AKT1—malignant glioma	3.6e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CASP3—malignant glioma	3.58e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—IL2—malignant glioma	3.57e-05	0.000103	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CASP3—malignant glioma	3.57e-05	0.000102	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AKT1—malignant glioma	3.57e-05	0.000102	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—IL2—malignant glioma	3.56e-05	0.000102	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CASP3—malignant glioma	3.53e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—IL2—malignant glioma	3.53e-05	0.000101	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PPARG—malignant glioma	3.49e-05	0.0001	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTP1—malignant glioma	3.47e-05	9.96e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MMP9—malignant glioma	3.38e-05	9.71e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CB—malignant glioma	3.38e-05	9.7e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAT—malignant glioma	3.37e-05	9.69e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MMP9—malignant glioma	3.37e-05	9.68e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTEN—malignant glioma	3.37e-05	9.68e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—malignant glioma	3.37e-05	9.67e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PTEN—malignant glioma	3.36e-05	9.66e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PTEN—malignant glioma	3.35e-05	9.63e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—malignant glioma	3.35e-05	9.61e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MMP9—malignant glioma	3.34e-05	9.59e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PTEN—malignant glioma	3.32e-05	9.53e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AKT1—malignant glioma	3.28e-05	9.42e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AKT1—malignant glioma	3.27e-05	9.39e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—malignant glioma	3.26e-05	9.36e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AKT1—malignant glioma	3.24e-05	9.3e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NCOR1—malignant glioma	3.19e-05	9.15e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CD—malignant glioma	3.18e-05	9.14e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—VEGFA—malignant glioma	3.04e-05	8.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—VEGFA—malignant glioma	3.03e-05	8.69e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—STAT3—malignant glioma	3.01e-05	8.64e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—VEGFA—malignant glioma	3e-05	8.61e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—STAT3—malignant glioma	3e-05	8.61e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—STAT3—malignant glioma	2.97e-05	8.52e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTEN—malignant glioma	2.92e-05	8.38e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—malignant glioma	2.83e-05	8.12e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—malignant glioma	2.79e-05	8.02e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—malignant glioma	2.78e-05	8e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CB—malignant glioma	2.77e-05	7.97e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—malignant glioma	2.76e-05	7.92e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AKT1—malignant glioma	2.75e-05	7.9e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—malignant glioma	2.75e-05	7.89e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—malignant glioma	2.73e-05	7.85e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—malignant glioma	2.72e-05	7.82e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—malignant glioma	2.7e-05	7.75e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CAV1—malignant glioma	2.6e-05	7.46e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KRAS—malignant glioma	2.58e-05	7.41e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KRAS—malignant glioma	2.57e-05	7.39e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KRAS—malignant glioma	2.55e-05	7.32e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTEN—malignant glioma	2.4e-05	6.88e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—malignant glioma	2.38e-05	6.83e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—malignant glioma	2.37e-05	6.81e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CG—malignant glioma	2.37e-05	6.8e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—malignant glioma	2.36e-05	6.79e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—malignant glioma	2.34e-05	6.72e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AKT1—malignant glioma	2.31e-05	6.63e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—malignant glioma	2.29e-05	6.59e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—malignant glioma	2.29e-05	6.57e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PPARG—malignant glioma	2.28e-05	6.56e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—malignant glioma	2.26e-05	6.51e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CD—malignant glioma	2.08e-05	5.97e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—malignant glioma	2.06e-05	5.91e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AKT1—malignant glioma	1.94e-05	5.58e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKT1—malignant glioma	1.94e-05	5.56e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKT1—malignant glioma	1.93e-05	5.55e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKT1—malignant glioma	1.91e-05	5.49e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CB—malignant glioma	1.81e-05	5.21e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—malignant glioma	1.8e-05	5.16e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—malignant glioma	1.69e-05	4.86e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AKT1—malignant glioma	1.68e-05	4.83e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTEN—malignant glioma	1.57e-05	4.5e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AKT1—malignant glioma	1.38e-05	3.97e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.11e-05	3.17e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AKT1—malignant glioma	9.03e-06	2.59e-05	CbGpPWpGaD
